Koers Can-Fite BioPharma Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
CANF
IL0010944739
Farmaceutische producten
Omzet 2024 * | 900K 3,35 mln. 836K | Omzet 2025 * | 900K 3,35 mln. 836K | Marktkapitalisatie | 10,85 mln. 40,33 mln. 10,08 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -7 mln. -26,02 mln. -6,5 mln. | Nettowinst (verlies) 2025 * | -8 mln. -29,74 mln. -7,43 mln. | EV/omzet 2024 * | 12,1 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 12,1 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,97% |
Recentste transcriptie over Can-Fite BioPharma Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Motti Farbstein
CEO | Chief Executive Officer | 59 | 01-08-03 |
Pnina Fishman
FOU | Founder | 74 | 11-09-94 |
Ilan Cohn
FOU | Founder | 68 | 11-09-94 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Abraham Sartani
BRD | Director/Board Member | 76 | 01-01-01 |
Ilan Cohn
FOU | Founder | 68 | 11-09-94 |
Pnina Fishman
FOU | Founder | 74 | 11-09-94 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,61% | 89,08 mld. | |
+3,55% | 40,9 mld. | |
-14,40% | 32,25 mld. | |
+55,89% | 25,14 mld. | |
-15,96% | 15,39 mld. | |
-15,50% | 11,91 mld. | |
-41,29% | 11,89 mld. | |
-11,75% | 11,64 mld. | |
+7,87% | 9,03 mld. |